|
---|
Category:Letter
MONTHYEARML24274A3112024-09-30030 September 2024 Request for NRC Review and Endorsement of NEI 99-01, Development of Emergency Action Levels for Non-Passive Reactors, Revision 7 ML24255A0702024-09-0909 September 2024 09-09-24_NRC_Industry Timeliness Request Regarding Items Relied Upon for Safety ML24204A2162024-07-22022 July 2024 Withdrawal of Fee Exemption Request for Endorsement of NEI White Paper, Selection of a Seismic Scenario for an EPZ Boundary Determination ML24204A2082024-07-22022 July 2024 07-22-24_NRC_NEI Withdrawal of Fee Exemption Request for Wp Selection of Seismic Scenario for EPZ Determination ML24187A0552024-07-0303 July 2024 Fee Exemption Request for NEI White Paper Selection of Seismic Scenario for EPZ Determination ML24184C1212024-07-0202 July 2024 NEI - Request for NRC Endorsement of NEI 24-05 Revision 0, an Approach for Risk-Informed Performance-Based Emergency Planning ML24173A2712024-06-14014 June 2024 NEI - Proposed Changes to Inspection Procedure (IP) 71130.10, Cybersecurity ML24165A0862024-06-13013 June 2024 NEI White Paper - Proposed Control Room Dose Acceptance Criteria Supporting RG 1.183 R2 ML24165A0852024-06-13013 June 2024 NEI White Paper - Impact of Higher Source Term Fractions on EQ Doses ML24165A0872024-06-12012 June 2024 NEI White Papers Supporting NRC Workshop Discussions Regarding Nuclear Regulatory Commissions (NRC) Potential Changes to Regulatory Guide 1.183 ML24152A3242024-05-31031 May 2024 NEI Concept Paper: Regulation of Rapid High-Volume Deployable Reactors in Remote Locations ML24159A7312024-05-23023 May 2024 05-23-24 Nuclear Energy Institute Letter to the U.S. Nuclear Regulatory Commission Re Industry Comments on Buildings as Items Relied on for Safety ML24135A1982024-04-23023 April 2024 SFAQ No 2022-02, SAE Program Requirements - NEI Withdrawal Letter ML24078A2212024-03-15015 March 2024 3-15-24 NEI Letter Aveil from Juhle on Pur ML24061A0572024-02-29029 February 2024 Endorsement of NEI 08-09, Revision 7, Changes to NEI 08-09 Cyber Security Plan for Nuclear Power Reactors ML24023A0392024-01-22022 January 2024 NEI Comments on the Information Collection Renewal for Domestic Licensing of Special Nuclear Material, Docket Id NRC-2023-0118 ML23355A1972023-12-14014 December 2023 NEI, Comments on NRC Draft Resolution of SFAQ 2022-02, SAE Program Requirements ML23219A1672023-10-25025 October 2023 Response Letter to Fee Exemption Request for Pre-Submittal Activities, Review, and Endorsement of NEI 20-07 ML23270B9002023-09-27027 September 2023 NEI Letter Request for an Extension of Comment Period on Proposed Revision to Standard Review Plan Section 15.0, Introduction - Transient and Accident Analyses, Docket Id NRC 2023 0079 ML23268A0102023-09-22022 September 2023 NEI, Fee Exemption Request for Endorsement, Review and Meeting to Discuss Draft Nuclear Energy Institute Technical Report NEI 23-01, Operator Cold License Training Plan for Advanced Nuclear Reactors ML23241A8612023-08-25025 August 2023 Consolidated Industry Comments to NRC Regulatory Issue Summary 2023-02, Scheduling Information for the Licensing of Accident Tolerant, Increased Enrichment, and Higher Burnup Fuels ML23236A4992023-08-24024 August 2023 Industry Feedback on Region II Fuel Cycle Facility Construction Oversight Workshop Held August 15, 2023, and Suggested Topics for Additional Public Meetings in Fall 2023 ML23256A1622023-08-0101 August 2023 Incoming NEI Letter Dated August 1, 2023 Regarding Increase in Fees 2023-2025 ML23206A0292023-07-24024 July 2023 Incoming Fee Exemption Request for Pre-Submittal Activities, Review, and Endorsement of NEI 20-07 ML23143A1232023-06-22022 June 2023 NRC Fee Waiver Request for Draft NEI 23-01 ML23200A1662023-05-30030 May 2023 NEI Proposed Metrics for a Performance-Based Emergency Preparedness Program ML23116A0732023-05-25025 May 2023 Letter to Hillary Lane in Response to a Request for a Fee Exemption for NEI 23-03 ML23135A7332023-05-0909 May 2023 NEI Comments on NRC Safety Culture Program Effectiveness Review ML23110A6762023-04-18018 April 2023 04-18-23_NRC_NEI 23-03 Review + Endorse ML23110A6752023-04-18018 April 2023 04-18-23_NRC_Fee Waiver for NEI 23-03 ML23110A6782023-04-18018 April 2023 Request for Review and Endorsement of NEI 23-03, Supplemental Guidance for Application of 10 CFR 50.59 to Digital Modifications at Non-Power Production or Utilization Facilities ML24120A2702023-04-0404 April 2023 Melody Rodridguez NEI Comment on Controlled Unclassified Information ML23107A2302023-03-31031 March 2023 NEI Letter, to Andrea Veil, NRC, Regarding Industry Recommendations for a 10 CFR 50.46a/c Combined Rulemaking ML23083B4622023-03-24024 March 2023 Transmittal of NEI 22-05 Revision a, Technology Inclusive Risk Informed Change Evaluation (Tirice) Guidance for the Evaluation of Changes to Facilities Utilizing NEI 18-04 and NEI 21-07 ML23138A1662023-03-24024 March 2023 Transmittal of NEI 22-05 Revision a, Technology Inclusive Risk Informed Change Evaluation (Tirice) Guidance for the Evaluation of Changes to Facilities Utilizing NEI 18-04 and NEI 21-07 ML23060A3272023-03-0101 March 2023 NEI, Wireless Cyber Security Guidance ML23060A2142023-03-0101 March 2023 NEI, Request for NRC Endorsement of NEI White Paper, Enabling a Remote Response by Members of an Emergency Response Organization, Revision 0 ML23023A2752023-01-23023 January 2023 Request for Extension of Comment Period from the Nuclear Energy Institute on PRM-50-124 - Licensing Safety Analysis for Loss-of-Coolant Accidents ML22348A1122023-01-17017 January 2023 Letter to Richard Mogavero Response to Fee Exemption NEI 08-09 Revision 7 ML22353A6082023-01-11011 January 2023 U.S. Nuclear Regulatory Commission Report of the Regulatory Audit of the NEI-Proposed Aging Management Program Revision to Selective Leaching Program (XI.M33) ML22349A1012022-12-12012 December 2022 LTR-22-0343 Ellen Ginsberg, Sr. Vice President, General Counsel and Secretary, Nuclear Energy Institute, Expresses Concerns Related to Issuance of Regulatory Issue Summary 2022-02; Operational Leakage ML22336A0372022-11-16016 November 2022 Fee Exemption Request for NEI 08-09 Revision 7 - Changes to NEI 08-09 Cyber Security Plan for Nuclear Power Reactors ML22321A3152022-11-16016 November 2022 NEI Letter with Comments on Significance Determination Process Timeliness Review ML22298A2262022-10-25025 October 2022 Endorsement of NEI 15-09, Cyber Security Event Notifications, Revision 1, Dated October 2022 ML22298A2302022-10-17017 October 2022 Submittal of NEI 22-03, Draft Revision 0, Nuclear Generation Quality Assurance Program Description ML22207B6512022-07-26026 July 2022 NEI, Full Fee Exemption Request for Industry Guidance Proposal - Weather Related Administrative Controls During Transient Outdoor Dry Cask Operations ML22195A1662022-07-14014 July 2022 NEI, Draft G of NEI 99-01, Development of Emergency Action Levels for Non-Passive Reactors, Revision 7 ML22195A0202022-07-13013 July 2022 07-13-22 NRC Fee Exemption Request for NEI 21-05 Review ML22195A0672022-07-13013 July 2022 Fee Exemption Request for Review and Meeting to Discuss Draft Nuclear Energy Institute Technical Report NEI 21-05, Reporting Guidance for Licensees with Risk-Informed Licensing Bases ML22159A2772022-06-28028 June 2022 Response Letter to Richard Mogavero for Fee Exemption for the Nuclear Regulatory Commission Review Ad Endorsement of NEI 15-09, Revision 1 2024-09-09
[Table view] |
Text
SUSAN PERKINS-GREW Senior Director, Nuclear Security and Incident Preparedness 1201 F Street, NW, Suite 1100 Washington, DC 20004 P: 202.739.8016 spg@nei.org nei.org June 19, 2017 Mr. Joseph Anderson Chief, Reactor Licensing Branch Division of Preparedness and Response Office of Nuclear Security and Incident Response U.S. Nuclear Regulatory Commission Washington, DC 20555-0001
Subject:
Industry Comments on EPFAQ 2017-001 Project Number: 689
Dear Mr. Anderson:
The industrys comments on draft EPFAQ 2017-001 are shown below and in the attached document.
- 1. We suggest including references to Initiating Condition (IC) AA1 from NEI 99-01, Revision 6, in the discussion of Emergency Action Level (EAL) changes. Similar to ICs AS1 and AG1, IC AA1 has EALs based on a multiple of the EPA PAGs - in this case, 1% of the PAG value. Since many sites have implemented NEI 99-01, Revision 6, the EPFAQ should address IC AA1 as well. Following the staffs approach for depicting changes to ICs AS1 and AG1, weve included a suggested Markup-Draft of IC AA1 showing the acceptable changes (which involve removal of the 50 mrem thyroid CDE thresholds).
- 2. We are proposing a new basis statement and related developer note for IC AA1; the added text is highlighted in yellow in the attachment. The statement and note would help licensees maintain consistency with NRC guidance and current licensing bases related to Radiological Environmental Monitoring Programs. Specifically, the proposed additions clarify that liquid releases should continue to be monitored and assessed under applicable RETS/ODCM requirements (i.e., EPA PAG and ICRP 60 dose assessment assumptions and methodologies should not be used).
- 3. With respect to the discussion on endorsed EAL guidance, the staff should consider adding a statement indicating that the emergency classification scheme for Virgil C Summer Nuclear Station, Units 2 and 3, is endorsed as described in NRC letter, Williams to Jones, dated April 10, 2017.
Likewise, the emergency classification scheme for Vogtle Electric Generating Plant, Units 3 and 4, is
Mr. James Anderson June 19, 2017 Page 2 endorsed by NRC letter, Williams to Whitley, dated May 18, 2017.
- 4. The staffs Markup-Draft of AS1 and AG1 both state, The EPA PAGs are expressed in terms of the sum of the effective dose equivalent (EDE) and the committed effective dose equivalent (CEDE), or as the thyroid committed dose equivalent (CDE). For the purpose of these IC/EALs, the dose quantity total effective dose equivalent (TEDE), as defined in 10 CFR Part 20, is used in lieu of sum of EDE and CEDE [committed effective dose equivalent].
Note that the reference to CEDE is deleted in the first sentence but retained in the second. It would appear that the deletion of CEDE in the first sentence was an error and, therefore, the paragraph should read, The EPA PAGs are expressed in terms of the sum of the effective dose equivalent (EDE) and the committed effective dose equivalent (CEDE), or as the thyroid committed dose equivalent (CDE). For the purpose of these IC/EALs, the dose quantity total effective dose equivalent (TEDE), as defined in 10 CFR Part 20, is used in lieu of sum of EDE and CEDE [committed effective dose equivalent].
This comment also applies IC AA1; we have shown the corrected version of the above paragraph in our Markup-Draft of IC AA1.
Questions regarding these comments should be directed to Mr. David Young (202-739-8127 or dly@nei.org).
Sincerely, Susan Perkins-Grew Attachment c: Mr. Ray Hoffman, NSIR/DPR/RLB/ORLT, NRC Mr. Don Johnson, NSIR/DPR/RLB/ORLT, NRC Ms. Patricia Milligan, NSIR/DPR, NRC NRC Document Control Desk